SHINE SA, October 2018 Access to PEP after an eligible exposure to HIV is a medical emergency. Your response to patients presenting for PEP can support them in preventing a life-long infection with HIV. A brief, online training module has been created to support health professionals to: • Increase your understanding of PEP as an emergency presentation and vital HIV prevention measure • Assist you...
ASHM, October 2018 HIV PrEP Update for GPs and Practice Nurses This training will provide GPs, Nurses, and Health Professionals working in primary care an update on strategies available for the prevention of HIV transmission, focusing on prevention particularly pre-exposure prophylaxis (PrEP). – Date Tuesday, 23 October 2018 – Venue Mercure Grosvenor, 125 North Terrace, Adelaide SA...
ICASO, September 2018 Since its announcement, Undetectable equals Untransmittable (U=U) has become a call to action to assert that when someone living with HIV has an undetectable viral load they cannot transmit HIV. Additionally, the U=U message is evolving to challenge notions of HIV infectivity, vulnerability and stigma. The science behind the U=U message provides the evidence that we can...
European Medicines Agency, 18/05/2018 The European Medicines Agency (EMA) is evaluating preliminary results from a study which found 4 cases of birth defects such as spina bifida (malformed spinal cord) in babies born to mothers who became pregnant while taking dolutegravir. While EMA is assessing the new evidence it has issued the following precautionary advice: Dolutegravir HIV medicines should...
BMC Public Health, 2018 18:527, Abstract Background Advances in medical treatment for HIV are driving major changes in HIV policy and practice, including the encouragement of intake and adherence to HIV antiretroviral treatment (ART) by people living with HIV (PLHIV) for both personal and public health benefits. However, there is increasing recognition that achieving these goals will require a...
Centre for Social Research in Health, UNSW, 2017 The latest findings from the PrEPARE Project have now been published. The PrEPARE Project is a longitudinal study of Australian gay and bisexual men’s attitudes to biomedical HIV prevention, particularly PrEP and treatment as prevention (TasP). With the unprecedented scaling up of PrEP access in many states over the last few years, we have...